Big Gain For Revance Therapeutics, Inc.
Mon, Aug 12, 2024 at 07:16 PM
Revance Therapeutics, Inc. (RVNC:NASDAQ) soared at $6.6, representing a gain of 87%. On Mon, Aug 12, 2024, RVNC:NASDAQ hit a New 2-Week High of $6.6. The stock appeared on our News Catalysts scanner on Mon, Aug 12, 2024 at 12:44 PM in the 'AGREEMENT' category. From Mon, Jul 29, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Mar 01, 2024 at $7.56 with a volume of 3M+.
About Revance Therapeutics, Inc. (RVNC:NASDAQ)
Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
Top 10 Gainers:
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 360%
- PS International Group Ltd. (PSIG:NASDAQ), 127.72%
- Kubient Inc. (KBNT:NASDAQ), 100%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 86.97%
- Interactive Strength Inc. (TRNR:NASDAQ), 79.05%
- Unico American Corporation (UNAM:NASDAQ), 75%
- Conifer Holdings, Inc. (CNFR:NASDAQ), 53.85%
- Oragenics, Inc. (OGEN:NYSEMKT), 48.57%
- WaveDancer Inc. (WAVD:NASDAQ), 45.41%
- 60 Degrees Pharmaceuticals Inc. (SXTP:NASDAQ), 44.69%